CRABP2 and pulmonary fibrosis: While our preliminary results are promising regarding the feasibility and utility of CRABP2 as a novel diagnostic candidate gene in IPF, further investigation is warranted to determine whether observed increases in CRABP2 levels associate with the disease progression and severity of fibrosis in preclinical models of pulmonary fibrosis.